Veracyte Inc risk profile
23 Normal where most of the sector sits
Measured 1 September 2026 from VCYT's filed statements. Recomputed nightly.
23 (Normal), driven by Market expectation at 61, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 61 | Stretched | Volatile | One-year price volatility — 62.5% |
| Operating pressure | 0 | Contained | Stable | Input-cost exposure — 0.01 |
| Cash conversion | 11 | Contained | Stable | Capital spending against operating cash — 0.07x |
| Leverage and coverage | 0 | Contained | Stable | Net debt to EBITDA — -4.08x |
| Competitive position | 38 | Normal | Stable | R&D-intensity gap against peers — -7.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.